Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
14,740.00    200.00 (1.38%)
Bid:
14,720.00
Ask:
14,780.00
Spread: 60.00 (0.408%)
Market Cap: £1.12b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

Acquisition

23 Mar 2007 09:15

Goodwin PLC23 March 2007 Goodwin PLC ("Goodwin" or the "Company") 23 March 2007 ACQUISITION OF NOREVA GmbH Goodwin, the mechanical and refractory engineering group, announces theacquisition of 75% of the share capital of Noreva GmbH ("Noreva"), amanufacturer of non return nozzle check valves located in Monchengladbach,Germany for an initial consideration of £2.8 million in cash. In the year to 31 December 2006 Noreva generated turnover of Eur 7.3 million (£5 million), profit before tax of Eur 0.42 million (£0.288 million) and has gross assets of Eur 4.3 million (£2.9 million) audited. The remaining 25% share interest, which is owned equally by the two currentManaging Directors of Noreva, Messrs R. Kurzenberg and M. Sattelberg (the"Managing Directors"), who are to continue to serve Noreva in their presentcapacity following the acquisition, is subject to put options exercisable by the Managing Directors no sooner than 5 years, and a call option exercisable byGoodwin PLC no earlier than 12 years, from the date of completion of theacquisition. The initial consideration is £2.8 million in cash, together with £0.6 millionpayable to Noreva (i.e. funds retained within the Goodwin group) for a perpetualtechnology licence. A deferred consideration of an additional £1.0 million willbe paid in two instalments, payable after three and five years after completion,respectively. The consideration in case of the exercise of the put and/or calloption will be either £1.0 million for the remaining 25 % of the Novera sharesor is to be calculated based on 10 times annual average pre-tax profit of Noreva for three years prior to the exercise of the option, or a combination of both calculation methods, depending on, inter alia, the term of service of therespective Managing Director. The Company believes that Noreva is a complementary business and anticipatessignificant value being created from the excellent synergy in the marketing andproduction capacity opportunities between Noreva and Goodwin's UK basedsubsidiaries Goodwin International Ltd and Goodwin Steel Castings Ltd (the"Goodwin Companies"). The Goodwin Companies manufacture and supply dual platenon-return check valves for the oil and gas industry worldwide, whereas Norevasupplies a complementary but more costly and faster-acting nozzle check valve to applications requiring less backflow and pressure surge. Noreva and the Goodwin Companies will continue to benefit from each others'technology and marketing resources, which are also complementary. Financing fromGoodwin will enable Noreva to extend its facility in Monchengladbach and anagreed cooperation in the area of distribution will enable each company toreduce lead times and provide a faster service to their customers and achieveincreased sales. The acquisition of Noreva will enable the Goodwin Companies and Noreva tofurther strengthen their relative market positions through the ability to offercomplete check valve solutions to their principal markets in the hydrocarbon,processing and water industries. Francis Gaffney, Director and General Manager of Goodwin International Ltd anda main board director of Goodwin PLC, will become a Managing Director of Noreva,together with the existing Managing Directors. Enquiries: John GoodwinTel: +44 1782 220000Goodwin PLC END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
6th Oct 20212:38 pmRNSResult of AGM
31st Aug 20217:00 amRNSPosting of Annual Report and Accounts
26th Aug 202110:25 amRNSDeath of an Employee
11th Aug 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
13th May 20214:41 pmRNSSecond Price Monitoring Extn
13th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
30th Apr 20214:35 pmRNSPrice Monitoring Extension
23rd Apr 20212:52 pmRNSDirector/PDMR Shareholding
8th Apr 20214:40 pmRNSSecond Price Monitoring Extn
8th Apr 20214:36 pmRNSPrice Monitoring Extension
6th Apr 20214:42 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
8th Mar 202111:18 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSHalf-year Report
11th Dec 20201:53 pmRNSDirectorate Change
5th Nov 202011:46 amRNSDirector/PDMR Shareholding
30th Oct 20207:00 amRNSIssue of Equity and Director/PDMR Shareholding
12th Oct 20202:11 pmRNSDirector/PDMR Shareholding
7th Oct 20202:55 pmRNSResult of AGM
9th Sep 20202:46 pmRNSDirector/PDMR Shareholding
27th Aug 20204:40 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
27th Aug 20203:00 pmRNSPosting of Annual Report and Accounts
13th Aug 20207:00 amRNSFinal Results
22nd Jun 20207:00 amRNSSupply Agreement
8th Jun 20207:00 amRNSCOVID-19 and Liquidity Update
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20204:36 pmRNSPrice Monitoring Extension
12th Feb 20204:35 pmRNSPrice Monitoring Extension
5th Feb 202012:07 pmRNSSecond Price Monitoring Extn
5th Feb 202012:02 pmRNSPrice Monitoring Extension
19th Dec 20197:00 amRNSHalf-year Report
16th Oct 20193:37 pmRNSDirector/PDMR Shareholding
15th Oct 20192:49 pmRNSIssue of Equity and Director/PDMR Shareholding
11th Oct 20194:40 pmRNSSecond Price Monitoring Extn
11th Oct 20194:35 pmRNSPrice Monitoring Extension
8th Oct 201910:34 amRNSDirector/PDMR Shareholding
2nd Oct 20194:06 pmRNSResult of AGM
30th Aug 20192:57 pmRNSPosting of Annual Report and Accounts
22nd Aug 20197:00 amRNSFinal Results
21st Aug 20194:35 pmRNSPrice Monitoring Extension
20th Aug 201912:07 pmRNSSecond Price Monitoring Extn
20th Aug 201912:02 pmRNSPrice Monitoring Extension
14th Aug 20194:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.